agilon health (NYSE:AGL – Free Report) had its price objective trimmed by Barclays from $5.00 to $2.00 in a research report released on Monday morning,Benzinga reports. The brokerage currently has an underweight rating on the stock.
Several other equities analysts have also commented on AGL. Benchmark reaffirmed a “buy” rating and set a $9.00 price target on shares of agilon health in a research report on Thursday, August 8th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $8.00 price target on shares of agilon health in a research report on Wednesday, August 7th. Deutsche Bank Aktiengesellschaft dropped their price target on shares of agilon health from $5.00 to $4.00 and set a “hold” rating for the company in a research report on Friday, August 9th. William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research report on Friday, November 8th. Finally, Citigroup reissued a “sell” rating and issued a $2.50 price objective (down previously from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. Three analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $6.38.
View Our Latest Analysis on agilon health
agilon health Stock Performance
agilon health (NYSE:AGL – Get Free Report) last announced its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same period in the previous year, the company posted ($0.06) EPS. As a group, research analysts forecast that agilon health will post -0.35 earnings per share for the current year.
Insider Activity at agilon health
In other news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction that occurred on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 3.20% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in AGL. J.Safra Asset Management Corp boosted its stake in agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after acquiring an additional 3,625 shares during the last quarter. City State Bank bought a new position in shares of agilon health in the 3rd quarter worth about $52,000. CWM LLC lifted its position in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the last quarter. Nisa Investment Advisors LLC bought a new position in shares of agilon health in the 2nd quarter worth about $60,000. Finally, Bleakley Financial Group LLC bought a new position in shares of agilon health in the 1st quarter worth about $65,000.
About agilon health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
- Five stocks we like better than agilon health
- How is Compound Interest Calculated?
- Rocket Lab is the Right Stock for the Right Time
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- SoundHound AI Will Advance By Triple Digits in 2025: Here’s Why
- What is the Dogs of the Dow Strategy? Overview and Examples
- Celsius Holdings: Big Drop, Big Opportunity? Analysts Say Yes
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.